ニツタ コウサク
Nitta Kosaku
新田 孝作 所属 その他 その他 職種 非常勤嘱託 |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読なし |
表題 | [Bone disease in the field of CKD-MBD]. |
掲載誌名 | 正式名:Clinical calcium 略 称:Clin Calcium ISSNコード:(0917-5857)0917-5857(Linking) |
巻・号・頁 | 26(6),pp.875-80 |
著者・共著者 | Yajima Aiji, Tsuchiya Ken, Yokota Hiroki, Nitta Kosaku |
担当区分 | 最終著者,責任著者 |
発行年月 | 2016/06 |
概要 | The pathophysiology and treatment for renal bone disease have made remakable progress. Moreover, osteocyte reseach has made tremendous progress. In the clinical aspect, (1) hyperphosphatemia, (2) hyperparathyroid and hypoparathyroid bone disease in patients with chronic kidney disease, (3) increased serum level of fibroblast growth factor 23 (FGF-23) and(4) reduced level of Klotho should be taken into consideration when analyzing these conditions. On the other hand, hyperphosphatemia must be successfully treated. Hyperparathyroid bone disease has been successfully treated with vitamin D sterol, cinacalcet hydrochloride and parathyroidectomy, however, the treatment of hypoparathyroidism inpatient with diabetes or non-diabetes met with high hurdles. We must treat these patients in thinking about osteocytic perilacunar/canalicular system. |
DOI | CliCa1606875880 |
PMID | 27230843 |